International Vaccine Institute
Seoul, Korea, Republic of
Purpose
to support the process development and scale up activities at SK Chemicals for the development of Vi-DT conjugate vaccine to support a large scale immunogenicity clinical trial (P3) and WHO PQ of the vaccine in the 2020-2022 timeframe.
Division
Global Health
Date
June 2018
Region Served
GLOBAL
Committed amount
$4,526,417
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
70
Grantee location
Seoul, Korea, Republic of
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.